Member Info for Dosanddonts

Commitment from distributors is great but high stock levels driven by high in-stocking from last year is not great! Maintaining high stock levels is also great but based on revenue this year that not the case as guessing most of the £0.5m will be from the 5 new EU countries. Resolving cash flow & 2026 revenue predictions are key here to move the SP north. As I’ve said imo Eroxon has a place in the market but will take time which I think the commercial partners have realised & a change in strategy by the big partners is happening with a longer timescale for revenue generation which means a smaller marketing spend. The pipeline products will hopefully also help with the partners.

This comment in RNS ain’t good news either, implies no stock replenishment for sometime.

“Current stocks in all European markets remain high, reflecting both the scale of initial sell-in and lower consumer purchase rates than predicted by Cooper.”

What is interesting here, is if eventually Haleon decide this is not for them as sales aren’t high enough, then they will have done all the hard work to market it to the smaller number of people it works for, so FUM can cut out the middleman & sell direct to retailer or the customer online. Increasing profits for FUM dramatically! Just a thought & was the reason FUM setup their own CMO’s to keep control! Or maybe WDS4000 has Haleon interested long term.

Don’t like the new Eroxon intense comments that it increases the sensory effects which was compared with people that the product had an effect on anyway? So if it don’t work at all does that mean it still don’t work?

A company called promscent that produces a delay spray, has been marketing there product themselves for a decade and is now making headwind in the market but it has took a long time. Maybe FUM could eventually come good who knows even as a failed product to the masses.

Laura please stop cutting and pasting RNS’s with nothing to say yourself, other people can read an RNS we don’t need you!!!!!

Eu & USA have been selling initial ordered product in 24 worth £8million to FUM, US didn’t start selling until Oct, so question is how much has been sold as reorders will start coming in. A placing benefits nobody at these prices unless LB is willing to invest more cash? Seems to me a short term commercial loan would be more beneficial as CMO’s are now setup and ongoing costs should be minimal now JB and AH have departed and we get rid of some non exec directors who add zero value. I hope there’s not a placing!

To be fair to the Lord he isn’t far wrong, the elephant in the room here is if in 24 the EU CMO issued penalties of £0.8m for not hitting min orders, what are the penalties going to be in 25 with EU & USA CMO’s & zero sales? This imo could bankrupt them , but no mention of this in update. So they have either resolved this with the EU cmo & don’t have this clause in the USA cmo or their hiding this bomb shell from us? FUM failed here as had no experience of setting up manufacturing cmo’s which cost us a big chunk of our initial profits & now this is a chain around FUM’s neck due to min orders! Greed & incompetence by JB & co! This imo will be sold to partners who will finish the job off & reap the rewards, but the sell off will be higher than the current £12m valuation along with the right to Eroxon intense, WSD4000 & CMO manufacturing. The Lord why not mention this instead of your BS!

Wow Laura so you can regurgitate an RNS, for F**k sake please give your own opinion!!!!

anybody heard of vitaros cream, it is also a topical cream applied to the head of the ***** to increase blood flow. first released in 2012 with high expectations similar to eroxon that didn’t materialise due to similar factors as eroxon. ended up getting split up & sold off to partners but still for sale today but with a high price tag. other issue is it still has side effects & cardiovascular risk. was proven in trials to be 80% effective!

anyway point is eroxon is still selling just not in the massive numbers predicted and probably never will unless eroxon intense has somehow been super charged! but it’s not going to be the death of the product and an asset they could sell worse case scenario.

Issue here is who is going to give up cheap PDE5 inhibitors for Eroxon no one! & everyone & their dog is on them! Would anyone swap morphine for paracetamol not likely! So the people trying this are older ED patients with heart issues who can’t take inhibitors, which we now know it dosnt work well on! I guess selling as a sexual enhancer may have been a better option & maybe what FUM is looking at, it takes away the stigma as well! I don’t think this is dead in the water yet, time will tell. Would be interesting to know the status on UK sales as penetration was deeper, interesting when they said that sales in UK were additional sales to other ED treatments, so was not taking away from other products! Yes the majority older people with heart issues probably! My advise don’t invest in Aim it’s a con!

Issue here is nobody still has any idea what actual sales are still, we know well below expectations but is there scope for sales whatever they are to increase?? F**k knows but I live in hope or Im delusional! They are saying the US uptake is slow, as is EU uptake! not that the product dosnt work! Sales decline is BS, more a case of slow uptake & revenue in 24 was from in stocking! The reason why JB & AH are gone because their financial accounting was ludicrous & forecasting outrageous!

So much for the new CEO, this has been done purposely to sink the share price & LB will buy a shed load for a few million to see us through! What happened to the review and the new plans going forward? Where are the 5 additional countries & Eroxon intense release date end of 25? Let’s remember the product is selling prob around revenue of £3m per year, that stock from 24 is still being sold but they release a figure that they know is lower than actual real sales in 25. Granted 24’s were inflated! SHOCKINGLY poor RNS with a figure that misleads, guessing the positive spin is yet to come once LB load up!

Exactly & why when the product had potential,?uk advertising started off well, then nothing? But why advertise a product when a better version is coming out! Shot themselves in the foot imo!

Where is the marketing & advertising? Is everything on hold for Eroxon intense and stock is being depleted on purpose. As I keep saying Eroxon intense will replace Eroxon if it delivers better results , so why bother with Eroxon standard! Why would Haleon push sales, when a better product is coming which has a better chance of working on more people?? They f’d up as brought the product to market too early, should have improved product & released this new Eroxon intense (if you believe them anymore), absolute idiots! Viagra came out at the highest dose then was reduced not the other way round!

Sorry to rant but they had the opportunity to be frank about the business regarding overall sales but again nothing! Eroxon intense will just replace Eroxon, as no side effects anyway & generally the reason people look for lower dose! Another useless RNS what a joke,,wish I’d bailed a year ago f img idiots!

& why the hell release this before the mid year financials, it’s not exactly rosy news! & tells us shareholders nothing again! Are we sure they sacked JB?

From my recollection were we not told that revenue from Haleon was only recognised when Haleon made sales & not stock delivery??? So how comes no revenue this year from US? Also if not requiring stock what is CMO for US charging in contract fines for min orders? Will be greater than EU CMO & who is paying that? Something don’t add up, either way they are in the S*it, but revenue makes no sense again! So much for transparency with new CEO!

It was never promoted as a fix for all or a replacement for PDE5 inhibitors period! It was a new treatment that worked in 10mins for ED in mainly the mild to moderate cases!

Just been to Chicago & when there noticed Eroxon is still in lock boxes in CVS, but to be honest pretty much everything is in lock boxes over there! They have assistance call buttons, so someone comes to you to remove from lock boxes. Clearly a massive issue with theft on lots of products even shampoo.

Good drink that Darty 🤣

Tell you what dumbfounds me is that when testing this product they realised that the product Dermasys without the drug element was as effective on its own! I except that sometime treatments are created in this way. My point anyway is that you don’t go around like JB acting like you & the company did a great job, telling your shareholders that the companies R&D are amazing! It was luck and with any luck with that idiot gone the F*ckwit CFO and hopefully some more cling on directors to follow, just maybe we can strike gold again or at least silver!

The reviews on this are ridiculous, Who the hell buys an 8 pack to try it as all reviews appear to be first time users??? One person ‘’should have listened to the other reviews’’? What so you bought an 8 pack at double the price to try it instead of the 4 pack??? Positive is this is mowing selling 1k+